Insider Transactions Reported by 8 Insiders of IGC Pharma, Inc.

Symbol
IGC on NYSE
Location
Potomac, MD

There are no Buy or Sell transactions made by insiders since 22 Jan 2025

IGC Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) 10%+ Owner $4,700,000 22 Mar 2024
Ram Mukunda CEO, Director $1,686,906 17 Oct 2025
Claudia Grimaldi PFO, Director $479,221 17 Oct 2025
RICHARD K. PRINS Director $411,375 19 Jan 2026
James Moran Director $315,134 17 Oct 2025
Rohit Goel Senior Director of Finance&PAO $79,900 13 May 2021
John E. Lynch Director $45,696 31 May 2022
TERRY L. LIERMAN Director 17 Oct 2025

Recent Insider Transactions by Companies or Individuals for IGC Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.